Psoriatic Arthritis
News
Rheumatology clinics find success with smoking cessation referral program
Clinics that adopted a protocolized, EHR-based approach to checking for readiness to quit saw a 26-fold increase in quit-line referrals.
Article
Apremilast Uses and Relevance to the Military
Apremilast is a versatile and easy-to-use therapeutic option for treatment of psoriasis and psoriatic arthritis. Dermatologists should consider...
News
Researchers stress importance of second COVID-19 vaccine dose for infliximab users
Significantly lower antibody concentrations seen after a first dose of the Pfizer or AstraZeneca vaccine in users of infliximab vs. vedolizumab...
Conference Coverage
Bimekizumab superior to adalimumab in head-to-head psoriasis study
The response to bimekizumab was notably fast.
Conference Coverage
Experts highlight recent breakthroughs in psoriatic arthritis
Signal of possible gender disparity in PsA response to biologics sparks questions.
News
COVID-19 vaccination in RMD patients: Safety data “reassuring”
Two studies show mainly mild reactions and favorable antibody responses in patients with rheumatic and musculoskeletal diseases after vaccination...
News
FDA warning letters target OTC cannabidiol product claims for pain relief
The FDA sent warning letters to two manufacturers for illegal marketing of drugs containing cannabidiol (CBD) and a failure to comply with current...
Conference Coverage
Checkpoint inhibitor–induced rheumatic complications often arise late
Rheumatologic adverse events associated with immune checkpoint inhibitors can happen later in the course of treatment but also can continue after...
Conference Coverage
To improve psoriatic arthritis outcomes, address common comorbidities
Depression and obesity are associated with poor treatment response in PsA.
Conference Coverage
Recent psoriasis pathophysiology insights carry treatment implications
“The primary problem in psoriasis is not so much the inflammatory activity, but the ability to turn off the activity.”